Arnold Ventures’ Post

Our Co-founder John Arnold joins Bloomberg's Joe Weisenthal and Tracy Alloway on the latest episode of the Odd Lots podcast. In their interview, John shares his deep insights into #energypolicy, market dynamics, and the transformative power of #philanthropy. Whether you're interested in the future of #energy or how strategic giving can drive impactful change for American families, communities and businesses, this conversation is a must-listen. Hear the full episode: https://bloom.bg/3KRj1S5

Arnold Ventures applauds Senators Mike Crapo, Ron Wyden, and the United States Senate Committee on Finance on the introduction of bipartisan legislation to improve fraud resilience and benefit delivery in unemployment insurance. Read our full statement here: https://lnkd.in/gDJ6jNQJ

Pharmaceutical companies have incredible influence and political power which they have used for far too long to keep drug prices inappropriately high. Read more in the statement from our Executive Vice President of Health Care Mark E. Miller, PhD: https://lnkd.in/dG32SDig

Today, the Senate unanimously passed the Federal Prison Oversight Act. This important legislation is the first step in addressing the ongoing crisis in our nation's prisons that is harming staff and incarcerated people alike. Read our statement: https://lnkd.in/gzEA_fP4

Hospital systems are buying up physician practices and then charging more for the same care, including services like MRIs, allergy skin tests, and chemotherapy; all of which are safely performed in independent physician offices. This is wrong, and today Arnold Ventures is proud to join more than two dozen groups comprised of thought leaders, employers, physicians, and patient advocates to call on the United States Senate Committee on Finance to take action to protect patients from these higher costs. Read our joint letter: https://lnkd.in/gsng7dsR #SameServiceSamePrice #HealthCare #SiteNeutral

Over 5 million #Medicare beneficiaries struggle to afford prescription medications. In 2022, 37% of Americans were not able to afford a $400 emergency expense. Now, with the median launch list price of new drugs at over $180,000, many Americans are having to choose between their #health and their livelihoods. Now is the time to address the cost of prescription medications. Learn more: https://lnkd.in/gGKCrNmd

📢 With support from Arnold Ventures, J-PAL North America is launching a new initiative to pair researchers with #criminaljustice organizations, and create new #evidence about what ideas and interventions actually work. As part of this initiative, J-PAL North America will act as a “matchmaker” between qualified CJ researchers and governments, nonprofits, and foundations that want to put the effectiveness of their promising CJ programs to the test. Read more in our interview with Vincent Quan, co-executive director of J-PAL North America, on how the organization’s new initiative will create high-quality #research that, in turn, can lead to more effective #policy interventions and improved outcomes for people, families, and communities: https://lnkd.in/gRQ5dgVH

In the final installment of our series profiling SSRC's new Criminal Justice Innovation Fellows, we spoke with Zachary Porreca, a postdoctoral fellow in the CLEAN unit at Università Bocconi in Milan, Italy, where he studies the economics of crime. As part of the new SSRC fellowship, Porreca plans to undertake several projects. Specifically, he'll study peer networks within state #prison systems, and how they predict a person’s peer networks in other facilities as they move through #prisonsystems as they serve their sentence. Separately, he plans to study the #labormarket impacts of programs that offer insurance policies to people who have recently been convicted of a crime, and whether that makes employers more likely to hire them. Read more about his #research projects: https://lnkd.in/guFjKrC7 Social Science Research Council (SSRC)